Matthias Moll

11PUBLICATIONS
9CO-AUTHORS
Radiation therapyBehavioural epidemiologyNatural language processingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2026
Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: a review of prospective studies.

|Jun 03, 2024
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.

Matthias Moll, Łukasz Magrowski, Martina Mittlböck

|Mar 15, 2024
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients.

Matthias Moll, Elisabeth Nechvile, Christian Kirisits

|Jan 05, 2024
The role of artificial intelligence in informed patient consent for radiotherapy treatments-a case report.

M Moll, G Heilemann, Dietmar Georg

|Jun 21, 2023
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation.

Matthias Moll, Gregor Goldner

|Oct 27, 2022
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.

Łukasz Magrowski, Oliwia Masri, Jakub Ciepał

Pageof 2

Frequent Collaborators

2 joint publications

Marcin Miszczyk

1 joint publications

G Heilemann

1 joint publications

Dietmar Georg

1 joint publications

P Kuess